IRADIMED CORP — Form 10-Q
Filed July 31, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
Roger Susi (CEO/President) and John Glenn (CFO) certified the Form 10-Q for the quarter ended June 30, 2026, filed July 31, 2026. Both officers attested that the financial statements fairly present the company's financial condition and results of operations, that disclosure controls and procedures are effective, and that no material weaknesses or fraud were identified in internal controls over financial reporting.
Why this rating
Routine Sarbanes-Oxley certification; standard periodic disclosure with no material deficiencies, changes, or events disclosed.
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.